Previous publications by our lab examined the effectiveness of Nr2e3 as a therapeutic for NR2E3-associated RP as well as other forms of RP that do not possess an NR2E3 mutation [19]. The gene discussed is NR2E3; the disease is retinitis pigmentosa 1.